Healthcare Services

Global Computer-Aided Drug Discovery Market Forecast 2026–2035 Presenting Long-Term Industry Expansion Insights

March 31, 2026March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Computer-Aided Drug Discovery Market By The End Of 2030?

The computer-aided drug discovery market has seen rapid expansion in recent years. It is forecast to grow from $7.56 billion in 2025 to $8.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.9%. This historical growth can be attributed to factors such as the increasing complexity of drug development processes, a rise in R&D expenditure within pharmaceuticals, the expansion of computational biology capabilities, the growing availability of biological data, and the widespread adoption of in silico modeling techniques.

The computer-aided drug discovery market size is expected to experience rapid expansion in the coming years. It is projected to reach $13.69 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.5%. This growth during the forecast period is attributable to increasing investments in AI-enabled drug discovery, a rising demand for quicker drug development cycles, the expansion of personalized medicine research, the growing integration of machine learning in pharmacology, and the increasing use of cloud computing for large-scale simulations. Major trends anticipated in this period include the rising use of AI-driven virtual screening, an increase in the adoption of molecular docking simulations, the growing incorporation of genomic data in drug design, the expansion of cloud-based drug discovery platforms, and an enhanced focus on the accuracy of predictive modeling.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19379&type=smp

Which Market Drivers Are Supporting The Expansion Of The Computer-Aided Drug Discovery Market?

The increasing incidence of cancer cases is projected to stimulate the expansion of the computer-aided drug discovery market in the future. Cancer constitutes a range of illnesses marked by the uncontrolled multiplication and division of abnormal cells within the body. The upward trend in cancer diagnoses stems from various influences, such as changes in lifestyle and urban environments, environmental pollution, intake of tobacco and alcohol, and differences in healthcare availability and public understanding. Computer-aided drug discovery provides a means to formulate drugs designed to target cancer cells possessing specific genetic mutations, thereby enabling the development of more personalized and effective cancer treatments. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, about 165,000 new cancer cases were identified in 2023, with projections indicating that approximately 204,000 cases will be diagnosed annually by 2033, contributing to an estimated total of 1.9 million cancer cases between 2024 and 2033. Hence, the growing prevalence of cancer cases is a key driver for the computer-aided drug discovery market.

Which Segment Classifications Shape The Computer-Aided Drug Discovery Market?

The computer-aided drug discovery market covered in this report is segmented –

1) By Type: Structure Based Drug Design, Ligand-Based Drug Design, Sequence-Based Approaches

2) By Therapeutic Area: Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, Other Therapeutic Areas

3) By End User: Pharmaceutical Companies, Biotechnology Companies, Research Laboratories

Subsegments:

1) By Structure Based Drug Design: X-ray Crystallography, Nuclear Magnetic Resonance (NMR) Spectroscopy, Molecular Docking Studies, Virtual Screening

2) By Ligand-Based Drug Design: Quantitative Structure-Activity Relationship (QSAR) Models, Pharmacophore Modeling, Ligand Similarity Searching, Fragment-Based Drug Design

3) By Sequence-Based Approaches: Protein Structure Prediction, Homology Modeling, Bioinformatics for Drug Target Identification, Genomic Data Analysis for Drug Discovery

Which Trends Are Shaping The Future Of The Computer-Aided Drug Discovery Market?

Leading companies operating in the computer-aided drug discovery (CADD) market are developing innovative solutions, including Artificial intelligence (AI) in drug discovery, to enhance the accuracy, speed, and efficiency of identifying potential drug candidates, optimizing lead compounds, and facilitating the development of personalized medicine. Artificial intelligence (AI) in drug discovery refers to the application of AI technologies, such as machine learning and deep learning, leveraging advanced algorithms to make discovering and developing new drugs faster, more efficient, and more precise. For instance, in December 2023, Merck KGaA, a Germany-based science and technology company, launched AIDDISONTM, the first software-as-a-service platform that integrates drug discovery and synthesis. Combining generative AI, machine learning, and computer-aided drug design, AIDDISONTM accelerates drug development by virtually screening compounds from over 60 billion chemical targets and recommending optimal synthesis routes. The platform is trained on two decades of pharmaceutical R&D data to identify drug-like candidates with properties such as non-toxicity and stability. By incorporating Merck’s SynthiaTM retrosynthesis API, AIDDISONTM optimizes drug manufacturing for efficiency and sustainability, aiming to reduce the cost and time of drug discovery.

Which Companies Are Expanding Their Footprint In The Computer-Aided Drug Discovery Market?

Major companies operating in the computer-aided drug discovery market are Dassault Systèmes SE, PerkinElmer Inc., Roivant Sciences Ltd., Certara Inc., Schrödinger Inc., XtalPi Inc., Dotmatics Limited, Simulations Plus Inc., ChemAxon Ltd., Exscientia Ltd., Insilico Medicine Inc., Collaborative Drug Discovery Inc., OpenEye Scientific Software Inc., Nimbus Therapeutics LLC, Atomwise Inc., GNS Healthcare Inc., BenevolentAI Limited, EpiVax Inc., Numerate Inc., Cloud Pharmaceuticals Inc., Aris Pharmaceuticals Inc., Cyclica Inc., BioSolveIT GmbH, Chemical Computing Group ULC, InSilicoTrials Technologies S.p.A

Read the full computer-aided drug discovery market report here:

https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report

How Is The Computer-Aided Drug Discovery Market Distributed Across Key Geographic Regions?

North America was the largest region in the computer-aided drug discovery (CADD) market in 2025. The regions covered in the computer-aided drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Computer-Aided Drug Discovery Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19379&type=smp

Browse Through More Reports Similar to the Global Computer-Aided Drug Discovery Market 2026, By The Business Research Company

Artificial Intelligence In Healthcare Diagnosis Global Market Report

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

Diagnostic Contract Manufacturing Global Market Report

https://www.thebusinessresearchcompany.com/report/diagnostic-contract-manufacturing-global-market-report

Ai In Medical Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795